San Donato Hospital
| イタリア | トルコ | オーストリア | |
| 腹腔内温熱化学療法 | から $25,000 | から $22,500 | から $40,000 |
| 胃ポリープ切除術 | から $5,500 | から $990 | から $5,000 |
| 結腸切除術 | から $20,000 | から $6,912 | から $22,000 |
| 大腸癌に対する放射線療法 | から $9,800 | から $5,800 | から $6,964 |
| ナノナイフ | から $18,000 | から $9,500 | から $25,000 |
Bookimedは結腸癌治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。結腸癌治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。結腸癌治療の旅路でお一人になることはありません。
Italian centers treat colon cancer using multidisciplinary resection techniques and advanced biological therapies. Specialized clinics merge oncological surgery with research under IRCCS accreditation. Surgeons utilize robotic platforms and laparoscopic methods to achieve high success rates in preserving bowel function and reducing recovery times.
Bookimed Expert Insight: While many search for oncology specialists, Italy’s IRCCS-accredited research hospitals like San Raffaele offer a unique advantage. These centers combine clinical care with active research, performing over 52,000 operations annually. This high volume directly correlates with better outcomes in complex gastrointestinal pathologies and tumor resections.
Patient Consensus: Patients value the multidisciplinary care teams that coordinate surgery and rehabilitation. They often highlight the relief of having advanced robotic options which help them return to daily life faster.
Leading Italian hospitals for colon cancer include San Raffaele, European Institute of Oncology, and Agostino Gemelli University Policlinic. These centers maintain IRCCS status for clinical excellence and research. They use robotic systems and advanced therapies to treat complex colorectal tumors and recurrent cases.
Bookimed Expert Insight: Italian centers holding Scientific Institute for Research, Hospitalization and Health Care (IRCCS) accreditation consistently report better outcomes for complex oncology. San Raffaele and San Donato Hospital both hold this status. This designation ensures patients access clinical trials and experimental treatments not available at standard general hospitals.
Patient Consensus: Patients recommend prioritizing IRCCS-designated centers in Northern Italy to secure shorter wait times. Many note that major university hospitals provide the most efficient multidisciplinary care for managing everything from initial diagnosis to ostomy reversal.
Italian centers report a 64% 5-year survival rate for colon cancer. This exceeds the 60% European average. Early-stage cases often reach 90% survival through curative surgery. Leading hospitals like San Raffaele utilize advanced systems for complex gastrointestinal oncology cases.
Bookimed Expert Insight: While overall survival is high, surgical volume is the most reliable predictor of success in Italy. Dr. Antonio Braun at Maria Cecilia Hospital has performed over 12,000 gastrointestinal interventions. Dr. Vincenzo Tondolo at Mater Olbia has completed 500 oncologic operations. Choosing specialists in Milan or Rome with over 500 procedures significantly improves long-term prognosis.
Patient Consensus: Patients note it is important to seek private care for faster staging. Delaying treatment in public systems can impact outcomes, but specialized centers provide excellent curative results.
Laparoscopic and robotic surgery are routine standard-of-care treatments for colon cancer at major Italian research hospitals. High-volume centers in cities like Milan and Rome utilize the Da Vinci robotic system for complex resections. These minimally invasive techniques typically reduce hospital stays to approximately 2–4 days.
Bookimed Expert Insight: While Italy is a global leader in robotic surgery, the volume of procedures is concentrated in IRCCS-accredited research hospitals. For example, San Raffaele performs over 52,000 operations annually. Patients should prioritize these accredited centers to ensure access to surgeons who perform over 50 robotic cases each year.
Patient Consensus: Patients note that active questioning is required as minimally invasive options might not be offered automatically. Those who chose laparoscopic routes emphasize significantly faster recovery times compared to traditional open surgery.
Plan for a 14 to 21 day stay in Italy for colon cancer surgery. Hospitalization typically lasts 2 to 6 days for laparoscopic procedures. Expect to remain in the country for 7 to 10 additional days for local recovery and follow-up monitoring. Long-haul travelers require 3 to 4 weeks total stay.
Bookimed Expert Insight: Data from top-tier Milan hospitals shows high surgical volume, where San Raffaele performs over 52,000 operations annually. This expertise often translates to faster recovery times through specialized laparoscopic care. Choose a facility where surgeons like Dr. Vincenzo Tondolo have performed over 500 oncologic laparoscopies to ensure the most efficient healing path.
Patient Consensus: Patients note that private clinics in Milan often expedite discharge within 5 to 10 days total. It is highly recommended to have a local translator or Italian speaker to help navigate hospital bureaucracy and recovery instructions.
Italian hospitals provide integrated psychological and nutritional support for colon cancer treatment. Special units at facilities like Gemelli University Hospital offer dedicated clinical dietetics. Over 77% of major Italian centers provide nutritional counseling and supplementation. Psychological services are often mandated during oncological follow-up.
Bookimed Expert Insight: Italian oncology departments often prioritize nutritional status before starting HIPEC or CyberKnife treatments. Our data shows hospitals in Rome and Milan integrate these supports into the standard protocol. Patients should look for centers with a Clinical Nutrition and Dietetics unit. This ensures recovery remains steady after intensive procedures like large intestine resections.
Patient Consensus: Patients note it is helpful to have dietitians explain how to manage food after bowel surgery. They emphasize that talking to a psychologist helps manage the stress of long chemoradiation cycles.
The Right to Oncological Oblivion (Law 193/2023) ensures Italian cancer survivors are not required to disclose their history 10 years after treatment. This period drops to 5 years for those diagnosed before 21. It strictly prohibits discrimination in banking, insurance, and adoption proceedings.
Bookimed Expert Insight: Italian legislation uniquely prioritizes rapid administrative access through IRCCS-accredited research hospitals. For instance, San Raffaele in Milan handles over 52,000 operations annually while maintaining research-integrated care. This synergy allows patients to access innovative treatments like the Da Vinci Robotic System or Tomotherapy while simultaneously triggering legal disability protections much faster than in typical community hospitals.
Patient Consensus: Patients emphasize applying for Legge 104/92 certification immediately after diagnosis. This grants essential rights like priority health queues and specific tax relief for recovery costs.